Welcome to the e-CCO Library!

OP010: Azathioprine dose reduction in patients with inflammatory bowel disease on combination therapy: a prospective study
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

E. Del Tedesco1, S. Paul2, H. Marotte3, C. Jarlot1, N. Williet4, J. M. Phelip4, L. Peyrin Biroulet5, J. F. Colombel6, X. Roblin*4

Created: Friday, 22 February 2019, 9:49 AM
OP010: Long term efficacy and safety of Ustekinumab for Crohn's disease: results from IM-UNITI long-term extension through 2 years
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Sandborn W.1, Rutgeerts P.2, Gasink C.3, Jacobstein D.3, Gao L.-L.3, Johanns J.3, Sands B.4, Hanauer S.B.5, Targan S.6, Ghosh S.7, de Villiers W.J.S8, Colombel J.-F.4, Feagan B.G.*9

Created: Wednesday, 20 February 2019, 10:36 AM
OP010: Shallow whole-genome sequencing predicts the future cancer risk of low-grade dysplastic lesions arising in ulcerative colitis
Year: 2018
Source: ECCO '18 Vienna
Authors:

I. Al Bakir1,2*, K. Curtius1, A.-M. Baker1, T.S.O. Clarke1, M. Moorghen3, M. Jansen4, M. Rodriguez-Justo4, S. Leedham5, T. Graham1*, A. Hart2*

Created: Thursday, 21 February 2019, 9:14 AM
OP011: Comparison of adalimumab monotherapy and a combination with azathioprine for patients with Crohns disease: a prospective, multicentre, open-labelled clinical trial (DIAMOND study)
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

T. Matsumoto*1, S. Motoya2, K. Watanabe3, T. Hisamatsu4, H. Nakase5, N. Yoshimura6, T. Ishida7, S. Kato8, T. Nakagawa9, M. Esaki10, M. Nagahori11, T. Matsui12, Y. Naito13, T. Kanai14, Y. Suzuki15, M. Nojima16, M. Watanabe11, T. Hibi17

Created: Friday, 22 February 2019, 9:49 AM
OP011: Etrolizumab treatment leads to early improvement in symptoms and inflammatory biomarkers in anti-TNF-refractory patients in the open-label induction cohort of the phase 3 HICKORY study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Peyrin-Biroulet L.*1, Feagan B.G.2, Mansfield J.3, Rubin D.T.4, Arulmani U.5, Maciuca R.5, Tyrrell H.6, Thommes J.5, Tole S.6

Created: Wednesday, 20 February 2019, 10:36 AM
OP011: Integration of whole-exome sequencing and RNA sequencing of intestinal biopsies in inflammatory bowel disease identifies inflammation-dependent effects
Year: 2018
Source: ECCO '18 Vienna
Authors:

R. Barbieri1*, W. Uniken Venema1, A. Vich Vila1, Y. Li1, L. Franke1, F. van Dijk1, N. De Klein1, M. Swertz1, S. Sanna1, M.D. Voskuil1, M. Rivas2, R. Xavier2, M. Daly2, G. Dijkstra1, E.A. Festen1, R.K. Weersma1

Created: Thursday, 21 February 2019, 9:14 AM
OP012: IL-23 is centrally involved in mediating molecular resistance to anti-TNF therapy in Crohn’s disease patients
Year: 2018
Source: ECCO '18 Vienna
Authors:

H. Schmitt1*, U. Billmeier1, W. Dieterich1, T. Rath1, S. Sonnewald2, S. Reid2, S. Hirschmann1, K. Hildner1, M.J. Waldner1, J. Mudter3, A. Hartmann4, R. Grützmann5, C. Neufert1, T. Münster6, M.F. Neurath1, R. Atreya1

Created: Thursday, 21 February 2019, 9:14 AM
OP012: Perioperative use of vedolizumab is not associated with short-term postoperative infectious complications in patients with ulcerative colitis undergoing (procto)colectomy with ileal pouch-anal anastomosis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Ferrante M.*1, Schils N.1, De Buck van Overstraeten A.2, Vermeire S.1, Van Assche G.1, Wolthuis A.2, D'Hoore A.2

Created: Wednesday, 20 February 2019, 10:36 AM
OP012: Risk factors for colorectal neoplasia in ulcerative colitis: results from the largest and longest-running colonoscopic surveillance programme
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

C. H. R. Choi*1, 2, I. Al Bakir1, 2, N. S. J. Ding1, M. Moorghen1, S. Thomas-Gibson1, J. Warusavitarne1, B. Saunders1, M. Rutter3, T. Graham2, A. Hart1

Created: Friday, 22 February 2019, 9:49 AM
OP013: Disease management and outcomes of patients with Crohn's disease at high risk of recurrence. Results from PRACTICROHN study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Iborra M.*1, Martín Arranz M.D.2, Domènech E.3, García V.4, Gutiérrez A.5, Barreiro-de Acosta M.6, Cea-Calvo L.7, Romero C.7, Juliá B.7

Created: Wednesday, 20 February 2019, 10:36 AM
OP013: Evolution of corticosteroid use in Crohns disease patients between 1991 and 2014: results from the Dutch population-based Inflammatory Bowel Disease South Limburg cohort
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

S. Jeuring*1, 2, V. Biemans1, L. Liu1, T. Van den Heuvel1, 2, M. Zeegers3, 4, 
W. Hameeteman1, M. Romberg-Camps5, L. Oostenbrug6, A. Masclee1, 2, D. Jonkers1, 2, M. Pierik1, 2

Created: Friday, 22 February 2019, 9:49 AM
OP013: HLA-DQA1 contributes to the development of antibodies to anti-TNF therapy in Crohn’s disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Sazonovs1*, N.A. Kennedy2, C. Bewshea2, L. Moutsianas1, G.J. Walker2, K. De Lange1, J. Goodhand2, C. Anderson1, J. Barrett1, PANTS Investigator Consortium, T. Ahmad2

Created: Thursday, 21 February 2019, 9:14 AM
OP014: A multicentre, double-blind, placebo-controlled phase 3 study of ustekinumab, a human interleukins-12/23p40 mab, in moderate-severe Crohns disease refractory to anti-tumour necrosis factor α: UNITI-1
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

P. Rutgeerts*1, C. Gasink2, M. Blank3, Y. Lang2, J. Johanns2, L.-L. Gao2, B. Sands4, S. Hanauer5, B. Feagan6, S. Targan7, S. Ghosh8, W. de Villiers9, J.-F. Colombel10, S. Lee11, P. Desreumaux12, E. V. Loftus, Jr13, S. Vermeire14, W. J. Sandborn15

Created: Friday, 22 February 2019, 9:49 AM
OP014: Analysis of 1792 gut metagenomes reveals microbial treatment targets for inflammatory bowel disease and irritable bowel syndrome
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Vich Vila1*, F. Imhann1, V. Collij1, S.A. Jankipersadsing1, T. Gurry2, Z. Mujagic3, A. Kurilshikov1, M.J. Bonder1, J. Xiaofang2, E. Tigchelaar1, J. Dekens1, V. Peters1, M.D. Voskuil1, M.C. Visschedijk1, F. Eleonora A.M.1, G. Dijkstra1, A.A. Masclee3, M.H. Hofker1, R. Xavier4, E.J. Alm2, J. Fu1, C. Wijmenga1, D.M. Jonkers3, A. Zhernakova1, R.K. Weersma1

Created: Thursday, 21 February 2019, 9:14 AM
OP014: Histological remission is predictive of improved clinical outcomes in patients with ulcerative colitis: results from the TOUCHSTONE open-label extension
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Sandborn W.1, Feagan B.*2, D'Haens G.3, Levesque B.2, Pai R.4, Hanauer S.5, Wolf D.6, Vermeire S.7, Ghosh S.8, Li C.9, Penenberg D.9, Aranda R.9, Olson A.9

Created: Wednesday, 20 February 2019, 10:36 AM
OP015: Biomarker correlation with endoscopic outcomes in patients with Crohn’s disease: data from CALM
Year: 2018
Source: ECCO '18 Vienna
Authors:

W. Reinisch1*, R. Panaccione2, P. Bossuyt3, F. Baert4, A. Armuzzi5, S. Travis6, S. Danese7, W.J. Sandborn8, G. D'Haens9, S. Berg10, J.-F. Maa11, J. Petersson11, E. Neimark11, A.M. Robinson11, J.-F. Colombel12

Created: Thursday, 21 February 2019, 9:14 AM
OP015: Cost-effectiveness of laparoscopic ileocecal resection versus infliximab treatment of terminal ileitis in Crohn's disease: the LIR!C TRIAL
Year: 2017
Source: ECCO '17 Barcelona
Authors:

de Groof J.*1,2, Bemelman W.1, Eshuis E.2, Gardenbroek T.1, Bossuyt P.3, Bosmans J.4, van Dongen H.4, van Wagensveld B.5, Brink M.6, Consten E.7, Buskens C.1, D'Haens G.2, Stokkers P.8, Ponsioen C.2 LIR!C Study Group

Created: Wednesday, 20 February 2019, 10:36 AM
OP015: Results of ANDANTE, a randomised clinical study with an anti-IL6 antibody (PF-04236921) in subjects with Crohns disease who are anti-tumour necrosis factor inadequate responders
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

S. Danese*1, S. Vermeire2, P. Hellstern3, R. Panaccione4, G. Rogler5, G. Fraser6, A. Kohn7, P. Desreumaux8, R.W. Leong9, G.M. Comer10, F. Cataldi10, A. Banerjee10, M.K. Maguire11, C. Li10, N. Rath11, J. Beebe10, S. Schreiber12

Created: Friday, 22 February 2019, 9:49 AM
OP016: Development and validation of diagnostic criteria for IBD-unclassified (IBDU) in children: a multicentre longitudinal study from the paediatric IBD Porto Group of ESPGHAN
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

L. Birimberg Schwartz1, D. Zucker2, A. Akriv2, C. Salvatore3, F. Cameron4, I. Lazowska5, L. Yianni6, P. Siba7, S. Kolacek8, C. Romano9, S. Buderus10, A. Pærregaard11, J. C. Escher12, D. Turner*13

Created: Friday, 22 February 2019, 9:49 AM
OP016: Need for primary abdominal surgery, but not repeated surgery, has decreased: a nationwide study of temporal trends in Crohn surgery in Sweden 1990–2014
Year: 2018
Source: ECCO '18 Vienna
Authors:

D. Kalman1*, C. Nordenvall2, A. Hallqvist Everhov3, J.F. Ludvigsson4, M.C. Sachs5, A. Ekbom6, O. Olén7, P. Myrelid1

Created: Thursday, 21 February 2019, 9:14 AM